JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
TMFCX
Price
$22.49
Change
-$0.14 (-0.62%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs TMFCX

Header iconJVMTX vs TMFCX Comparison
Open Charts JVMTX vs TMFCXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
Touchstone Mid Cap Value C
Price$22.49
Change-$0.14 (-0.62%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs TMFCX Comparison Chart
Loading...
VS
JVMTX vs. TMFCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and TMFCX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. TMFCX (615M). JVMTX (0.73) and TMFCX (0.70) have matching dividends . JVMTX was incepted earlier than TMFCX: JVMTX (11 years) vs TMFCX (15 years). JVMTX is a more actively managed with annual turnover of: 41.00 vs. TMFCX (21.00). JVMTX has a lower initial minimum investment than TMFCX: JVMTX (0) vs TMFCX (2500). JVMTX annual gain was more profitable for investors over the last year : 19.27 vs. TMFCX (15.67). JVMTX return over 5 years is better than : 43.64 vs. TMFCX (30.53).
JVMTXTMFCXJVMTX / TMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years15 years-
Gain YTD11.0108.595128%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B615M3,805%
Annual Yield % from dividends0.730.70105%
Returns for 1 year19.2715.67123%
Returns for 3 years13.381.52879%
Returns for 5 years43.6430.53143%
Returns for 10 years63.3436.83172%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems